MIMESIS Newsletter #3: A novel systems biology approach to develop preclinical assets
MIMESIS NEWSLETTER #3, April 2018
A novel systems biology approach to develop preclinical assets from innovative drug discovery starting points inspired by viruses.
MIMESIS is a research and innovation project coordinated by ENYO Pharma and funded under the highly selective H2020 – SMEInstrument – Phase 2 call that aims at: “Dedicated support to biotechnology SMEs closing the gap from lab to market”. The MIMESIS project was launched on Nov 2016 for 2 years.
We will keep you updated regularly on the progress of the program.Download newsletter (PDF)